Olli Vuolteenaho Selected Research

Olli Vuolteenaho Research Topics

Disease

11	Hypertension (High Blood Pressure) 07/2011 - 01/2002
10	Hypertrophy 06/2014 - 03/2002
8	Heart Failure 06/2014 - 03/2002
8	Myocardial Infarction 01/2014 - 03/2003
6	Hypoxia (Hypoxemia) 09/2017 - 05/2006
6	Fibrosis (Cirrhosis) 06/2014 - 03/2003
5	Cardiomegaly (Heart Hypertrophy) 01/2014 - 03/2003
4	Ventricular Remodeling 06/2014 - 03/2003
4	Left Ventricular Dysfunction 06/2014 - 01/2005
4	Cognitive Dysfunction 11/2013 - 04/2010
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2010 - 09/2002
3	Osteoarthritis 01/2022 - 06/2017
3	Rheumatoid Arthritis 01/2022 - 06/2017
3	Hyperglycemia 08/2017 - 09/2013
3	Inflammation (Inflammations) 01/2017 - 02/2006
3	ST Elevation Myocardial Infarction 01/2015 - 03/2010
3	Aortic Valve Stenosis (Aortic Stenosis) 01/2012 - 01/2009
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2008 - 08/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2011 - 11/2009
2	Infarction (Infarctions) 07/2011 - 09/2010
2	Heart Diseases (Heart Disease) 09/2010 - 01/2005
2	Atrial Fibrillation 03/2008 - 05/2006
2	Body Weight (Weight, Body) 03/2007 - 11/2003
1	Ulcerative Colitis 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Weight Loss (Weight Reduction) 01/2021
1	Synovitis 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Myoma 10/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016
1	Hantavirus Infections 02/2014
1	Stroke (Strokes) 02/2014
1	Ganglion Cysts (Ganglion) 12/2012
1	Anemia 02/2012
1	Cardiomyopathies (Cardiomyopathy) 11/2010

Drug/Important Bio-Agent (IBA)

19	Natriuretic PeptidesIBA 01/2021 - 04/2002
11	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2014 - 03/2002
10	Angiotensin IIIBA 06/2014 - 01/2002
10	Messenger RNA (mRNA)IBA 07/2011 - 03/2002
8	Atrial Natriuretic Factor (ANF)IBA 02/2013 - 09/2002
7	Peptides (Polypeptides)IBA 07/2011 - 03/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2002
6	CytokinesIBA 01/2022 - 03/2008
6	pro-brain natriuretic peptide (1-76)IBA 07/2014 - 09/2004
6	CollagenIBA 06/2014 - 04/2004
5	ApelinIBA 09/2017 - 08/2003
4	Endothelin-1 (Endothelin 1)IBA 01/2009 - 11/2003
3	calcipotriene (calcipotriol)FDA LinkGeneric 01/2021 - 06/2017
3	Streptozocin (Streptozotocin)FDA Link 08/2017 - 09/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2010 - 01/2002
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2007 - 06/2004
2	Vitamin D FDA LinkGeneric 01/2021 - 10/2017
2	Troponin T (Troponin T1)IBA 01/2021 - 04/2002
2	nitroxIBA 09/2017 - 07/2014
2	Connective Tissue Growth FactorIBA 06/2014 - 09/2005
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 06/2007
2	procollagen Type III-N-terminal peptide (PIIP)IBA 03/2008 - 11/2004
2	Oxygen (Dioxygen)IBA 06/2007 - 05/2006
2	AdrenomedullinIBA 04/2006 - 06/2004
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2005 - 03/2003
2	AngiotensinsIBA 09/2005 - 03/2002
2	Losartan (Cozaar)FDA LinkGeneric 06/2003 - 09/2002
2	Captopril (Capoten)FDA LinkGeneric 03/2003 - 01/2002
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	ZymosanIBA 01/2021
1	Calcitriol (Calcijex)FDA LinkGeneric 10/2017
1	Hormones (Hormone)IBA 09/2017
1	ProteomeIBA 10/2016
1	GlycogenIBA 01/2016
1	InterleukinsIBA 01/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 06/2014
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2014
1	Monoclonal AntibodiesIBA 06/2014
1	Salmo salar cardiac natriuretic peptideIBA 02/2014
1	Myosins (Myosin)IBA 02/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2014
1	TWEAK ReceptorIBA 09/2013
1	Mitochondrial Uncoupling ProteinsIBA 09/2013
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2013
1	Simendan (Levosimendan)IBA 07/2013
1	Immune Sera (Antisera)IBA 12/2012
1	LipidsIBA 01/2012
1	Indicators and Reagents (Reagents)IBA 12/2011
1	phospholambanIBA 07/2011
1	DiureticsIBA 07/2011
1	Adenosine Triphosphatases (ATPase)IBA 07/2011
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 07/2011
1	Atenolol (Tenormin)FDA LinkGeneric 02/2011
1	Amlodipine (Norvasc)FDA LinkGeneric 02/2011
1	ThrombospondinsIBA 09/2010

Therapy/Procedure

3	Therapeutics 04/2011 - 03/2004
2	Injections 01/2021 - 04/2011
2	Percutaneous Coronary Intervention 01/2015 - 03/2010
1	Glycemic Control 01/2021
1	Intra-Articular Injections 01/2021
1	Cell Transplantation 01/2015
1	Transplantation 01/2015